Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
MIRACL, 2001 | atorvastatin | placebo | acute coronary syndrome | Low risk of bias | Suggesting | |
Colivicchi, 2002 | atorvastatin | usual care | acute coronary syndrome | Exploratory | Negative | |
PROVE IT - TIMI 22, 2004 | atorvastatin | pravastatin | acute coronary syndrome | | Suggesting | |
ESTABLISH, 2004 | atorvastatin | usual care | acute coronary syndrome | Exploratory | Negative | |
|
PROVE-IT, 2004 | atorvastatin high dose | pravastatin | diabetic | Low risk of bias | Suggesting | |
|
SALTIRE, 2005 | atorvastatin | placebo | aortic stenosis | Exploratory | Negative | |
|
MIRACL (AF ancillary study), 2001 | atorvastatin | placebo | | Exploratory | Negative | |
MIRACL (sub-group) (Schwartz), 2004 | atorvastatin | placebo | | Exploratory | Suggesting | |
Ozaydin, 2006 | atorvastatin | control | | Exploratory | Suggesting | |
ARMYDA-3 (AF ancillary study), 2006 | atorvastatin | placebo | | | Suggesting | |
Dernellis, 2006 | atorvastatin | placebo | | Exploratory | Suggesting | |
Chello, 2006 | atorvastatin | placebo | | Exploratory | Negative | |
Almroth, 2009 | atorvastatin | placebo | | Risk of bias | Suggesting | |
STOP-AF ongoing | atorvastatin | placebo | | | - | NCT00252967 |
|
Patti et al., 2006 | preoperative atorvastatin | placebo | | | Suggesting | |
Chello et al., 2006 | preoperative atorvastatin | placebo | | | Negative | |
|
AVERT, 1999 | atorvastatin high dose | angioplasty | secondary prevention | Risk of bias | Negative | |
MIRACL, 2001 | atorvastatin | placebo | acute coronary syndrome | Low risk of bias | Suggesting | |
Colivicchi, 2002 | atorvastatin | usual care | acute coronary syndrome | Exploratory | Negative | |
GREACE, 2002 | atorvastatin | usual care | secondary prevention | Risk of bias | Suggesting | |
ASCOT (women subgroup) , 2003 | Atorvastatin | placebo | women | Exploratory | Negative | |
Mohler, 2003 | atorvastatin | placebo | secondary prevention | Low risk of bias | - | |
Mohler III, 2003 | atorvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
ASCOT (diabetics sub group), 2003 | atorvastatin | placebo | diabetic patients | Exploratory | Negative | |
ASCOT, 2003 | atorvastatin | placebo | at risk hypertensive | Low risk of bias | Conclusive | |
CARDS, 2004 | atorvastatin | placebo | diabetic | Low risk of bias | Conclusive | NCT00327418 |
REVERSAL, 2004 | atorvastatin high dose | pravastatin | secondary prevention | Exploratory | Negative | |
PROVE-IT, 2004 | atorvastatin high dose | pravastatin | diabetic | Low risk of bias | Suggesting | |
PROVE IT - TIMI 22, 2004 | atorvastatin | pravastatin | acute coronary syndrome | | Suggesting | |
ESTABLISH, 2004 | atorvastatin | usual care | acute coronary syndrome | Exploratory | Negative | |
TNT, 2005 | atorvastatin high dose | atorvastatin | secondary prevention | Low risk of bias | Conclusive | NCT00327691 |
Vascular basis, 2005 | atorvastatin high dose | lovastatin | secondary prevention | Exploratory | Negative | |
SALTIRE, 2005 | atorvastatin | placebo | aortic stenosis | Exploratory | Negative | |
Deutsche Diabetes Dialyse Studie (4D), 2005 | atorvastatin | placebo | | Low risk of bias | Suggesting | |
Strey, 2005 | atorvastatin | placebo | heart failure | | - | |
IDEAL, 2005 | atorvastatin high dose | simvastatin | secondary prevention | Risk of bias | Suggesting | NCT00159835 |
TNT (diabetic sub group), 2006 | atorvastatin high dose | atorvastatin | diabetic patients | Exploratory | Suggesting | |
ASPEN (primary prevention sub group), 2006 | atorvastatin | placebo | diabetic | Exploratory | Negative | |
SPARCL, 2006 | atorvastatin | placebo | post stroke | Low risk of bias | Suggesting | NCT00147602 |
ASPEN, 2006 | atorvastatin | placebo | diabetic patients | Low risk of bias | Negative | |
ASPEN, 2006 | atorvastatin | placebo | diabetic | Low risk of bias | Negative | |
SAGE, 2007 | atorvastatin high dose | pravastatin | secondary prevention | Exploratory | Suggesting | |
|
ASCOT (diabetics sub group), 2003 | atorvastatin | placebo | diabetic patients | Exploratory | Negative | |
CARDS, 2004 | atorvastatin | placebo | diabetic | Low risk of bias | Conclusive | NCT00327418 |
TNT (diabetic sub group), 2006 | atorvastatin high dose | atorvastatin | diabetic patients | Exploratory | Suggesting | |
ASPEN, 2006 | atorvastatin | placebo | diabetic patients | Low risk of bias | Negative | |
ASPEN (primary prevention sub group), 2006 | atorvastatin | placebo | diabetic | Exploratory | Negative | |
|
Strey, 2005 | atorvastatin | placebo | heart failure | | - | |
Wojnicz, 2006 | atorvastatin | control | heart failure | | Negative | |
Sola, 2006 | atorvastatin | placebo | heart failure | | Negative | |
Yamada, 2007 | atorvastatin | control | heart failure | | Negative | |
|
ASCOT, 2003 | atorvastatin | placebo | at risk hypertensive | Low risk of bias | Conclusive | |
|
GAIN, 2001 | atorvastatin | usual care | | | Negative | |
ARMYDA, 2004 | atorvastatin | placebo | | | Suggesting | |
NAPLES II (Briguori), 2009 | atorvastatin | control | | | Suggesting | |
ARMYDA-RECAPTURE, 2009 | atorvastatin reload | placebo | | Low risk of bias | Suggesting | |
ESTATE ongoing | Atorvastatin | control | | | - | NCT00979940 |
|
Mohler III, 2003 | atorvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
REVERSAL, 2004 | atorvastatin high dose | pravastatin | secondary prevention | Exploratory | Negative | |
TNT, 2005 | atorvastatin high dose | atorvastatin | secondary prevention | Low risk of bias | Conclusive | NCT00327691 |
Vascular basis, 2005 | atorvastatin high dose | lovastatin | secondary prevention | Exploratory | Negative | |
IDEAL, 2005 | atorvastatin high dose | simvastatin | secondary prevention | Risk of bias | Suggesting | NCT00159835 |
SAGE, 2007 | atorvastatin high dose | pravastatin | secondary prevention | Exploratory | Suggesting | |
|
SPARCL, 2006 | atorvastatin | placebo | post stroke | Low risk of bias | Suggesting | NCT00147602 |